Quantcast

Latest Brain tumor Stories

2014-01-13 16:25:24

CINCINNATI, Jan. 13, 2014 /PRNewswire-USNewswire/ -- The diabetes drug metformin is also being tested in numerous clinical trials for treating different cancers, and several studies point to its apparent activation of a molecular regulator of cell metabolism called AMPK to suppress tumor growth. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) But new research appearing the week of Jan. 13 in Proceedings of the National Academy of Sciences (PNAS) suggests that...

2014-01-13 08:30:16

NEW YORK, Jan. 13, 2014 /PRNewswire/ -- SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), a biotechnology company focused on proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. "DelMar's lead drug candidate, VAL-083, is a...

2014-01-13 08:30:13

Topline Data Will Be Presented at Biotech Showcase HEIDELBERG, Germany, Jan. 13, 2014 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company, announced today the successful completion of its phase II proof-of-concept trial with APG101 in patients with recurrent glioblastoma. All endpoints of the randomized controlled trial that compared the efficacy and safety of a combination therapy of APG101 and radiotherapy versus radiotherapy alone were achieved or...

2014-01-11 23:02:39

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by EurekaAlert.org, discussing new research that has found a mechanism implicated in brain cancer and a drug that is proving to decrease brain tumor growth. New York, NY (PRWEB) January 11, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by EurekaAlert.org on January 1, 2014, that...

2014-01-10 23:22:56

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Bennett Nester, a 3-year old brain tumor patient who is focusing on bringing joy to others despite his own battle with the terrible disease. New York, NY (PRWEB) January 10, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Bennett Nester, a 3-year-old brain tumor patient whose efforts are bringing joy to children that are...

2014-01-09 16:25:42

Highlights Include ICT-107 Results to Date, Ongoing Data Analyses and Phase III Planning LOS ANGELES, Jan. 9, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today issued the following letter to shareholders providing an update on the Company's ICT-107 clinical program in patients with newly diagnosed glioblastoma (GBM). (Logo: http://photos.prnewswire.com/prnh/20140109/AQ43875LOGO) To Our Shareholders: Since the December 11, 2013 announcement of...

2014-01-08 12:31:02

2014 procedures expected to increase 31% over 8-year total as intraoperative MRI utilization expands to improve outcomes in growing number of neurosurgical applications MINNEAPOLIS, Jan. 8, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that an internal study of 40 worldwide VISIUS(®) Surgical Theatre hospital customers indicates that nearly 13,000 patients have been treated using intraoperative MRI (iMRI) since the first...

2014-01-07 08:32:13

HEIDELBERG, Germany, Jan. 7, 2014 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company, announced today that Thomas Hoeger, Ph.D., Chief Executive Officer, will present the results of the completed phase II efficacy trial in patients with recurrent glioblastoma at the Biotech Showcase(TM) in San Francisco. The presentation will take place on Tuesday, Jan. 14, at 4 p.m. PST at the Parc 55 Wyndham San Francisco - Union Square. "The results of this controlled phase II...

2014-01-04 23:25:06

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Western Australian Sutherlan Scudds for his undeniable strength and will to beat brain cancer. New York, NY (PRWEB) January 03, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, praises Australian national fencing champion, Sutherlan Scudds, for his positive outlook on his brain cancer diagnosis and treatment. According to a January 1st,...

2014-01-04 23:02:32

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by MySunCoast.com that discusses a new brain cancer treatment that will specifically target glioblastomas. New York, NY (PRWEB) January 04, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by MySunCoast.com that takes a deeper look into a new brain cancer treatment that will...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related